FDA Clearance Tracker · K241523
injeTAK Adjustable Tip Needle (DIS199; DIS201)
Last checked: Nov 19, 2026Latest source record: Aug 27, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Aug 27, 2024
Substantially Equivalent
Time to decision
90 days
Received May 29, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K241523
- Device name
- injeTAK Adjustable Tip Needle (DIS199; DIS201)
- Applicant
- Laborie Medical Technologies, Corp.
- Applicant location
- Portsmouth, NH
- Received
- May 29, 2024
- Decided
- Aug 27, 2024
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 876.1500
- Specialty
- GI, Urology & NephrologyUrology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code FBK. The earliest in FDA's data is K812057, decided Jul 31, 1981.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K241523
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Laborie Medical Technologies, Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Solar Compact (G4-1)510(k)
K240007 · Decided May 6, 2024 · 125 days after receipt
Device type: System, Gastrointestinal Motility (Electrical) (FFX) · GI, Urology & Nephrology
K234107 · Decided Apr 23, 2024 · 119 days after receipt
Device type: Monitor, Esophageal Motility, Anorectal Motility, And Tube (KLA) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.